Contents

Recent Patents on CNS Drug Discovery (Discontinued), Volume 3 - Number 2

Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent Developments

, 3(2): 77 - 93

Neal G. Simon, Christophe Guillon, Karine Fabio, Ned D. Heindel, Shi-fang Lu, Marvin Miller, Craig F. Ferris, Michael J. Brownstein, Carrie Garripa and Gary A. Koppel


DOI: 10.2174/157488908784534586




Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy

, 3(2): 94 - 103

Ada Maria Tata


DOI: 10.2174/157488908784534621




Tamoxifen as a Powerful Neuroprotectant in Experimental Stroke and Implications for Human Stroke Therapy

, 3(2): 104 - 108

Harold K. Kimelberg


DOI: 10.2174/157488908784534603




Is Plasma Amyloid-β a Reliable Biomarker for Alzheimers Disease?

, 3(2): 109 - 111

Henrik Zetterberg


DOI: 10.2174/157488908784534595




Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain Injury

, 3(2): 112 - 127

Jian Guan


DOI: 10.2174/157488908784534630




New Avenue of Research: Antiepileptic Drug and Estradiol Neuroprotection in Epilepsy

, 3(2): 128 - 137

Libor Velisek and Jana Veliskova


DOI: 10.2174/157488908784534577




Functional Interference of Dexamethasone on Some Morphine Effects:Hypothesis for the Steroid-Opioid Interaction

, 3(2): 138 - 150

Anna Capasso and Alberto Loizzo


DOI: 10.2174/157488908784534612




Patent Selections

, 3(2): 151 - 152

Bentham Science Publishers


DOI: 10.2174/157488908784534568




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science